FLOR VASQUEZ RIVERA: Open Payments
NPI 1073999827 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 18 payments from 10 companies in 2025. Trend: 2023 $163 · 2024 $725 · 2025 $813
Food & beverage: $613Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $226 |
| United Therapeutics Corporation | 4 | $166 |
| Verona Pharma, Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 1 | $102 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
Products named: Adempas, Tyvaso, Ohtuvayre, DUPIXENT, WINREVAIR, TEZSPIRE, VENASEAL, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
